Company: TCRG
Filing Date: 2025-03-21
Form Type: 10-K
Source: 0001185185-25-000206
Chunk: 4

Company: Cannaisseur Group Inc.
Filing Date: 2025-03-21
Form: 10-K
Item: Item 1
Chunk 4
---
 Trademarks

The
Company holds no patents or trademarks, nor, at this time, has any patent or trademarks pending.

Government
Regulation

CBD
Products are not subject to the Controlled Substances Act.

The
Agriculture Improvement Act of 2018 (“AIA” or “the Act”) exempted hemp-derived cannabidiol products (“hemp-derived
CBD products”) from the federal Controlled Substances Act (“CSA”). Specifically, the AIA, also known as the Farm
Bill of 2018, established a legal definition of “hemp”: the plant Cannabis sativa L. and any part of that plant, including
the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with
a delta-9 tetrahydrocannabinol [∆-9 THC] concentration of not more than 0.3% on a dry weight basis.

The
Act amends the CSA to exclude “hemp” from the definition of “marihuana.” It also amended the CSA to exclude
THC found in “hemp” from the “tetrahydrocannabinols” listed in Schedule I. Therefore, hemp-derived CBD products
that contain less than less than 0.3% of ∆-9 THC, such as those marketed by the Company, are not controlled substances under the
CSA. These amendments to the CSA took immediate effect on December 20, 2018.

By
way of background, the CSA establishes five “schedules” into which a substance with abuse potential may be classified.
Substances that fall under any one of the five schedules are subject to various requirements and restrictions enforced by the

U.S.
Drug Enforcement Administration (“DEA”). The most restrictive is Schedule I, which is reserved for those substances having
a high potential for abuse that do not have a currently accepted medical use, and that lack accepted safety for use under medical supervision.

Marijuana
has long been classified under Schedule I. Previously, DEA took the position that CBD met the expansive definition of “marijuana”,
which made it subject to Schedule I as well. Specifically, DEA created a code number in Schedule I for “marihuana extract,”
defined as “an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other
than the separated resin (whether crude or purified) obtained from the plant.” DEA made clear that